REX MD

Serial Number 90491808
Registration 6830324
700

Registration Progress

Application Filed
Jan 27, 2021
Under Examination
Approved for Publication
Jun 14, 2022
Published for Opposition
Jun 14, 2022
Registered
Aug 30, 2022

Trademark Image

REX MD

Basic Information

Serial Number
90491808
Registration Number
6830324
Filing Date
January 27, 2021
Registration Date
August 30, 2022
Published for Opposition
June 14, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 30, 2022
Registration
Registered
Classes
005

Rights Holder

LIFEMD, INC.

03
Address
236 5TH AVENUE, SUITE 400
NEW YORK, NY 10001

Ownership History

CONVERSION LABS, INC.

Original Applicant
03
New York, NY

CONVERSION LABS, INC.

Owner at Publication
03
New York, NY

CONVERSION LABS, INC.

Original Registrant
03
New York, NY

LIFEMD, INC.

New Owner After Registration #1
03
NEW YORK, NY

Legal Representation

Attorney
Howard Shipley

USPTO Deadlines

Next Deadline
941 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220830)
Due Date
August 30, 2028
Grace Period Ends
February 28, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Sep 5, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 30, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 30, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 14, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 14, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 25, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 5, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 28, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 28, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 28, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 28, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 22, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 22, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 21, 2022 ALIE A ASSIGNED TO LIE Loading...
Mar 18, 2022 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Mar 17, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 17, 2022 PETG O PETITION TO REVIVE-GRANTED Loading...
Mar 17, 2022 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Mar 14, 2022 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Mar 12, 2022 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 24, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 24, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 24, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 14, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 28, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 30, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Prescription and non-prescription medicines, namely, tablets, medicated creams, and medicated lotions for treating erectile dysfunction; Prescription and non-prescription medicines, namely, tablets, medicated creams, and medicated lotions for treating hair loss; Prescription and non-prescription medicines, namely, tablets, medicated creams, and medicated lotions for preventing premature ejaculation
First Use Anywhere: Nov 12, 2019
First Use in Commerce: Nov 12, 2019

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MD"